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Summary The emergence of non-communicable diseases (NCDs) follows multiple
aetiological pathways requiring recognition for effective control and prevention.
Infections are proving to be conventional, emerging and re-emerging aetiological
factors for many NCDs. This review explores the possible mechanisms by which infec-
tions induce NCDs citing examples of studies in Africa and elsewhere where NCDs
and infections are proposed or conﬁrmed to be causally linked and also discussesDeveloping countries the implications and challenges of these observations for science and medicine. The
need to re-evaluate and expand early community and individual preventive and con-
trol strategies that will lead to reduction and even elimination of NCDs especially in
Africa and other developing countries where infections are prevalent is highlighted.
© 2009 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Ltd. All rights reserved.
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ntroduction
on-communicable diseases (NCDs) are the com-
onest cause of death and disability worldwide,
ccounting for almost 60% of all deaths with inci-
ence rates assuming epidemic proportions in many
ountries of the world [1]. Eighty percent of deaths
rom NCDs occur in low and middle income coun-
ries of the developing world [1] and if nothing
s done to halt this trend it is projected that by
015 deaths from NCDs may increase by 15—27% in
hese countries [2]. The aetiology of most NCDs has
een linked to multiple risk factors including host
enetics and immune response, lifestyle and envi-
onmental risk factors [3]. Risk factors are deﬁned
s any attribute, characteristic or exposure of an
ndividual, which increase the likelihood of devel-
ping a disease or injury [4]. Physical inactivity,
lcohol excess, tobacco ingestion, excessive salt
ngestion, gender, age, obesity, high cholesterol and
nhealthy diet and many other factors are estab-
ished conventional risk factors for development of
any NCDs (Table 1) and they remain targets for
CD preventive and control strategies [3,4]. Over
he last two decades however, there has been an
mergence of novel aetiological factors (e.g. Heli-
obacter Pylori and peptic ulcer disease (PUD) [5]),
ovel risk factors (e.g. low birth weight and Type
I Diabetes mellitus [6]) and novel markers (e.g.
aised Homocysteine and cardiovascular diseases
7]) for many NCDs. NCDs causation can now be con-
eptualized as a continuum from womb to disability
r death. A successful and durable NCDs preventive
nd control strategy therefore requires a holistic
e
m
r
c................................................... 27
pproach where all possible primary and secondary
isk factors are targeted.
Infectious diseases are the commonest cause of
eath in Africa and rank third to cardiovascular
iseases and cancers respectively, as a cause of
eath worldwide [8]. As a result of improved labora-
ory diagnostic techniques and advances in science,
echnology, medicine and public health, many
CDs including cardiovascular diseases, cancers and
ndocrine diseases have now been associated with
n infectious risk factor. Infections therefore repre-
ent novel and emerging risks factors for NCDs with
he potential for preventative interventions.
An infectious (communicable) disease is deﬁned
s an illness caused by a speciﬁc infectious agent
r its toxic products that results from transmission
f that agent or its products from an infected per-
on, animal or reservoir to a susceptible host [9].
his agent can be transmitted either directly or
ndirectly through an intermediate plant or animal
ost, vector or inanimate environment [9]. NCDs
n the other hand are deﬁned as a disease or con-
ition that has no known causative agents that are
ransmitted from one affected individual to another
10]. However, with the increasing number of NCDs
eing associated with an infectious risk factor, the
istinction between an infectious disease and NCDs
s blurring and it is important to bring to the fore
heir linkages and interactions.
This review explores the role of infections in themergence of NCDs including possible pathogenetic
echanisms citing examples of infections where
esearch in Africa and elsewhere has suggested or
onﬁrmed a causal link to NCDs. The implications
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nd challenges of the knowledge obtained in pre-
enting and interrupting full blown emergence of
he relevant NCDs in the developing world become
bvious.
eterminants of NCD outcome following
nfection
he disease outcome following an infection is
etermined by a dynamic interaction between the
nfectious agent, the host and the environment. We
onsider each of these factors in turn.
ost
usceptibility to infection, disease development,
isease progression and disease severity are all
etermined by interplay of several host factors
ncluding age, sex, genetics, immune response
nd nutritional status. Acute rheumatic fever fol-
owing ˇ hemolytic streptococcus infection [11]
s, for instance, a disease of childhood, whereas
lzheimer’s disease that has been causally linked to
hlamydia infection is a disease of the elderly [12].
ender and sex hormones also determine disease
anifestations since androgens have been shown
o promote liver carcinogenesis [13] and this may
o a degree explain why Hepatitis B virus (HBV)-
elated liver cancer has been reported to be ﬁve
imes commoner in males than in females [14].
he effect of estrogens in stimulating antibody
including autoantibody) production and the effect
f testosterone in depressing antibody production
lso partly explains the higher incidence of autoim-
une diseases in females than males [15].
HLA type and immune genetic defects also deter-
ine disease outcome following an infection [16].
espite the known role of infections as a trigger for
utoimmune diseases there are discordant infec-
ions and autoimmune incidence rates between
ountries and continents. These differences have
een attributable to differences in HLA [16]. HLA
27 is common amongst Caucasians and hence cases
f Reiter’s arthritis are reported more frequently
mongst Caucasians in the western world than
mongst Africans [17].
HLA type may however protect against disease
evelopment following infection. HLA DR 1302 has
een shown from studies in Gambia and Ger-
any to protect against progression of HBV-related
hronic diseases by improving clearance of HBV
16]. Genetic polymorphism and mutations of inter-
eukin 10 (IL-10), transforming growth factor (TGF
), tumor necrosis factor (TNF) and other cytokine
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Fompelling needs for novel strategies in the develo
enes involved in immune protection and immune
egulation are all known to promote development
f many infection-related NCDs including asthma
nd allergy [17].
nfectious agent
he type of infection, the infecting dose, the
train involved and the virulence of the infecting
gent are all important determinants of the dis-
ase outcome. The ability of Helicobacter pylori
o induce peptic ulcer disease is determined by
he virulence of the infecting strain [5]. Conse-
uently, virulent strains produce products such as
he cytotoxin associated gene-pathogenicity island
cag-PAI) products, vacoulating cytotoxin (VacA)
nd urease which act together with a dysregu-
ated host immune response to promote gastric
nﬂammation and cause PUD [5]. Similarly, of the
bout 30 genotypes of human papilloma virus (HPV)
hat cause genital infection strains with genotypes
6 and 18 are known to induce cervical cancer
ttributable to their potent oncogenic properties
18]. Other strain-speciﬁc disease outcomes can be
een in group A ˇ hemolytic streptococcus-related
cute glomerulonephritis where M strains types 1,
, 4, 12, 18, 25, 49, 55, 57 and 60 are more likely
o cause acute glomerulonephritis [19] and malaria
here Plasmodium malariae is more likely than
ther species to cause immune complex mediated
alaria nephropathy [20,21]. The mechanisms that
nderlie how speciﬁc strains of an infection cause
CD is related to their ability to release cytotoxic
roducts and also to cause an exaggerated and dys-
egulated immune response that leads to tissue
amage.
nvironment
n addition to environmental risk factors, infections
ay increase the cumulative risk of developing a
CD by serving as triggers, co-factors or themselves
etiological drivers for NCD development. Infec-
ions as co-factors with environmental factors in
CD emergence is exempliﬁed in chronic obstruc-
ive pulmonary disease (COPD) where the lung
amaging effects of smoking are potentiated by
oncomitant respiratory tract viral infection [22].
The environment may also inﬂuence the immune
evelopment and host immune response and may
onsequently protect or predispose an individ-
al to developing a NCD. This analogy is typiﬁed
n the hygiene hypothesis proposed by Strachan
n 1989 [23] which states that an excessively
ygienic environment in early childhood may pre-
ispose some towards asthma, allergy, atopy and
utoimmune diseases. Early microbial exposure is
m
t
f
l
aworld 17
ssential for normal immune development [24].
nder excessively hygienic circumstances, early
hildhood infections are rare and the TH (T helper)
cytokines arm of the T helper lymphocytes is
referentially stimulated without modulation from
he TH1 cytokine arm. Hence, excessive activation
f TH2 cytokine arm predisposes hygienic children
o asthma and allergy. In Africa, the low inci-
ence of autoimmune and allergic diseases have
een attributed to chronic malarial parasitaemia
nd recurrent helminthes infestation both of which
nduce immunosuppressive and anti-inﬂammatory
esponses that prevent allergy and autoimmune
iseases [17,24]. In a pioneering experiment by
reenwood and Voller, infection of New Zealand
lack (NZB) and Fi hybrid mice with rodent malaria
arasite Plasmodium berghei yoeli suppressed the
pontaneous autoimmune disease of mice of these
wo strains [25]. Uncritical acceptance of this
ypothesis hygiene may however understate the
mportance of hygiene in prevention of infectious
iseases. While discouraging excessive hygienic
ractices that eliminate the beneﬁcial effects of
urrounding microbial ﬂora in a healthy primary
mmune response, effective hygienic practices that
revent clinical infection and promote healthy liv-
ng should always be emphasized and promoted.
echanisms of infectious aetiology of
CD
nﬂammation
he ability of an infectious agent and host to
nduce and sustain chronic inﬂammation is the
ocal mechanism involved in the infectious aetiol-
gy of most NCD and most NCD are characterized
athologically by evidence of chronic inﬂamma-
ion. Chronic inﬂammation is a feature of NCDs
ncluding atherosclerosis [26], peptic ulcer disease
5], and asthma [27]—–all possibly having an infec-
ious trigger. The role of microorganism in initiating
his injury and the subsequent development of a
CD is determined largely by dynamic interactions
etween the host, environment and the infectious
gent [28—31].
The persistence of infectious agents within the
ells and tissues of the host is the key driving
orce for chronic inﬂammation leading to NCDs.
or this reason, most infection-related NCD are
ore likely to follow chronic persistent viral infec-
ions and other intracellular bacteria, parasitic,
ungal and Prions infections than acute extracel-
ular infections (e.g. Staphylococcus spp.). Some
cute infections may however result in NCD via the
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‘‘hit and run’’ hypothesis [32]. This hypothesis sug-
gest that an infection ‘HITS’ by triggering an NCD
and ‘RUNS’ (becomes no longer present) when the
disease develops. Typical examples of NCD where
the ‘‘hit and run’’ hypothesis is thought to play
a role include Reiter’s arthritis and other reac-
tive arthritides that follow a past gastrointestinal
infection (e.g. Campylobacter, Shigella) and geni-
tal infections (e.g. Chlamydia urethritis) [28], and
also multiple sclerosis that has been postulated to
be triggered by childhood corona virus infections in
predisposed individuals [32,33].
Acute infections may also cause NCDs by initi-
ating a vicious chronic inﬂammatory cycle [34]. In
the development of COPD for instance, although
the evidence for a primary infectious aetiology is
inconclusive, recurrent bacteria infections such as
Streptococcus pneumonia is thought to initiate the
disease by causing lung damage [34]. Lung dam-
age in turn predisposes to further bacteria infection
setting up a vicious cycle that eventually lead to
chronic lung damage characteristic of COPD [34].
Infectious agents may also cause an NCD by
acting as Superantigens [35]. Superantigens are
components or products of infectious agents that
unspeciﬁcally activate T cells and result in an
exaggerated immune response characterized by
massive release of cytokines and chemokines [35].
NCD where infectious superantigens have been
implicated include Kawasaki disease, eczema and
rheumatoid arthritis [35].
Hypersensitivity and autoimmunity
The immune response to an infection may be
exaggerated (hypersensitivity) and occasionally
immune cells may directly attack host tissue
(autoimmunity). These operative immune mech-
anisms have been classiﬁed from type I to type
V [36,37]. Hypersensitivity and autoimmunity-
induced inﬂammation are important mechanisms
by which infections induce NCD. In the develop-
ment of speciﬁc NCD, a combination of two or more
types of hypersensitivity reactions may be involved
[36,38].
Autoimmunity and autoimmune diseases may be
triggered by infectious agents in genetically pre-
disposed individuals [20,38,39]. The mechanisms
involved include molecular mimicry, exposure of
hidden/sequestered antigens, neoantigen forma-
tion and immune dysregulation [38,39]. Molecular
mimicry (a process in which infectious agents share
a similar antigenic characteristics with components
of host tissue) is perhaps the most important mech-
anism by which most infections trigger autoimmune
diseases. In the pathogenesis of acute rheumaticD. Ogoina, G.C. Onyemelukwe
ever, heart and joint symptoms develop 1—2
eeks after group A ˇ hemolytic streptococcus
ecause the M proteins of ˇ hemolytic strepto-
occus share similar antigenic characteristics with
yosin, laminin, and other matrix proteins found
n the heart and joints and hence auto-antibodies
re directed against these and other tissues in pre-
isposed individuals [31]. Molecular mimicry is also
nown to play a role in the pathogenesis of sev-
ral other autoimmune diseases such as type 1 DM,
heumatoid arthritis and Graves’s disease [39].
Infections may alter immunological tolerance to
elf- and foreign antigens or may cause exposure
f novel cryptic or sequestered antigens located
ithin cells and tissues. This novel host-infectious
ntigen is recognized as foreign and subjected to
mmune destruction resulting in an autoimmune
isease. In the pathogenesis of rheumatoid arthri-
is, infections such as Mycoplasma and Parvovirus
ay expose novel antigens within the joints, the
lomerulus and other sites and may also alter self-
ntigens when infectious antigens become planted
n host tissues [38—40]. Pancreatic B cell cryp-
ic antigen exposure by viruses (Coxsackie B) has
lso been suggested as additional mechanism for
n infectious aetiopathogenesis of type 1 DM [38].
ellular transformation
wenty percent of cancers worldwide are caused
y infectious agents and infections rank second
nly to smoking as the commonest cause of can-
ers worldwide [41]. Carcinogenesis is a multi-step
rocess and infections may serve as triggers in one
r more these steps [42]. In the two hit hypothesis
f carcinogenesis, at least two genetic mutations
re required for cancers to develop. An inher-
ted germ-line mutation of the tumor suppressor
ene can only result in cancer if there is a muta-
ion of the second allele of the tumor suppressor
ene [42]. Infections amongst other factors have
een implicated in inducing these and other genetic
lterations that result in cancers. The mechanism
f infectious carcinogenesis may include the follow-
ng:
. Oncogene activation. Oncogenes are genes
that promote cellular growth. Infectious may
activate normal cellular oncogenes or may
themselves express oncogenes that accelerate
cell growth and result in malignancy. In the
development of HBV-related primary liver cell
carcinoma (PLCC), the X-protein of the virus
has been postulated to directly transactivate
viral genes and cellular oncogenes that promote
HBV replication and also encourage tumorige-
C ping
2
3
4
5
6ompelling needs for novel strategies in the develo
nesis [43,44]. In HPV-related cervical cancers
the E5 gene of the virus is an oncogene that
activates growth factors promoting carcinogen-
esis [18,45]. In the aetiopathogenesis of adult
T cell leukaemia, Human T lymphotrophic virus
1 (HTLV-1) Tax protein is an oncogene pro-
tein which activates the transcriptional factor
nuclear factor  (NF-) that promotes T cell
transformation to cancers [46]. In the same vein,
Epstein Barr virus (EBV) is known to induce chro-
mosomal translocations (involving chromosomes
8; 14, or 2; 8, or 8; 22) that cause deregula-
tion of the c-myc cellular oncogene expression
and subsequent development of Burkitt’s lym-
phoma [47]. Furthermore, the latent membrane
protein 1(LMP1) and Epstein Barr nuclear anti-
gen 2 (EBNA2) are oncogene products of EBV
implicated in the tumorigenesis of Hodgkin’s
lymphoma and other EBV-related non-Hodgkin’s
lymphomas [47]. These and several other EBV
oncogene products have also been linked to
the aetiopathogenesis of a number of cancers
including nasopharyngeal cancers [47].
. Loss of tumor suppressor ability. The p53 gene
and the Retinoblastoma (pRb) gene code for
anti-proliferative signals that suppress cancer
development by inhibiting cell division, inducing
programmed cell death (also known as apop-
tosis) and providing the opportunity for DNA
repair during a cell cycle [42]. These tumor sup-
pressor genes may become inactivated following
an infection. The E6 and E7 gene products of
HPV for instance, directly promote abnormal
cellular growth that result in cervical cancers
by degrading the p53 protein and inactivating
the pRb protein, respectively [10,45]. Aﬂatox-
ins produced from the fungus Aspergillus ﬂavus
have also been shown to cause a mutation in
codon 249 of the p53 gene and is thought to act
synergistically with HBV infection in promoting
development of PLCC [48,49]. In Zaria, north-
ern Nigeria, aﬂatoxin B1, B2, G1, G2 have been
found in liver cancer tissue as well as sera of
patients with PLCC [50,51].
. Chronic inﬂammation. Chronic inﬂammation
with repeated cycles of cell death and regen-
eration, release of oxygen free radicals and
reactive nitrogen radicals lead to DNA damage
and mutations. With every subsequent muta-
tion the risk of carcinogenesis is increased.
Chronic inﬂammation contributes to carcino-
genesis in HCV/HBV-related PLCC [39,40] and
Schistosoma haematobium-related bladder can-
cers [52] since infection with these agents is
characterized by repeated cycles of cell necrosis
and regeneration.world 19
Viruses can also promote abnormal cellular
proliferation by encoding inﬂammatory and cell
growth factors. Human herpes virus 8 (HHV8)
encodes a viral interleukin 6 (v-IL-6) and viral
G-protein coupled receptor (v-GPCR) both pos-
sess pro-inﬂammatory, pro-growth factors and
pro-angiogenic properties [53].
. Epithelial metaplasia. Infections like other car-
cinogens can directly cause cancers by provoking
metaplasia of epithelial surfaces. This is exem-
pliﬁed in Helicobacter pylori-related gastric
cancers where chronic atrophic gastritis results
in intestinal metaplasia of the gastric mucosa
with a consequent cellular dysplasia and cancer
development [5]. Chronic Schistosoma haema-
tobium infection also promotes development of
squamous carcinoma of the bladder by inducing
squamous metaplasia of the transitional epithe-
lium of the bladder [52].
. Release of carcinogens. Infections may also
cause release of carcinogens thereby promot-
ing carcinogenesis. In chronic schistosomiasis
and liver ﬂuke (e.g. Chlonorchis sinesis) infesta-
tion, chronic inﬂammation may result in release
of endogenous nitrosamines and exposure to
high concentrations of this carcinogen may
lead to neoplastic transformation [52]. Adult
schistosome and miracidia may also directly
liberate carcinogenic amines in the urine and
by causing urinary stasis also concentrate
urinary endogenous carcinogens. Absorption
of these carcinogens may damage the blad-
der epithelium and promote carcinogenesis
[52].
. Immunosuppression with loss of immunosurveil-
lance. Infections such as HIV that cause
predominant cellular immunosuppression are
characteristically associated with increased risk
of cancers. HIV infection results in both numer-
ical and functional defects in both CD4 and
CD8 T cells, cause dysfunctional natural killer
(NK) cell, interferon gamma (INF-) and IL-2
activities and generally provoke an unfavourable
TH2 biased cytokine dysregulation [54]. The
TH1 cytokines (INF-, IL-2), natural killer cells
(NK cells) and both CD4 and CD8 T lym-
phocytes are important elements involved in
tumor immunity and tumor surveillance [55].
These defects therefore predispose HIV patients
to cancers including Non-Hodgkin’s lymphoma,
cervical cancers, Kaposi’s sarcoma and other
cancers [56]. Malaria induced immunosuppres-
sion and polyclonal B cell activation is also
thought to encourage EBV transactivation and
transformation of B cells characteristic of Burki-
itt’s lymphoma [57]. The roles of HIV or chronic
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malaria in triggering lymphomas when associ-
ated with EBV infection have also been linked
to their ability to stimulate a TH2 B cell
growth promoting cytokine proﬁle and suppres-
sion of the TH1 tumor protective cytokines
[58].
Role of infections in emergence of
speciﬁc non-communicable diseases
Infections have been implicated in the emergence
of several non-communicable diseases but estab-
lishing a causal link has been challenging in most
studies. Table 2 gives examples of infections with
a known or probably aetiological role in the even-
tual emergence of NCDs. The following discussion
highlights some NCDs where infections are primary
aetiological factors or associated risk factors.
Prenatal infections and non-communicable
disease
NCD causation can be described as a continuum
from womb to tomb as an insult before and after
birth may subsequently promote the development
of NCDs. Evidence for this notion is typiﬁed in the
Baker’s hypothesis which suggest that fetal malnu-
trition and stress permanently affect development
and function of certain organs of the body and
predispose to the development conditions such as
insulin resistance, non-insulin dependent diabetes
mellitus (NIDDM), hypertension, stroke and coro-
nary heart disease in adult life [7,59].
Infections such as malaria, urinary tract
infections (UTI) and Toxoplasmosis, Rubella,
Cytomegalovirus and Herpes virus infections
are all known causes of fetal malnutrition and
intrauterine growth retardation [60,61] especially
in developing countries where these infections
are prevalent. In Africa, malaria in pregnancy is a
leading cause of fetal malnutrition and IUGR [60].
By directly causing fetal malnutrition, infections
can indirectly serve as risk factors in the eventual
development of NCD like Type 2 DM, hypertension,
obesity and ischemic heart disease in genetically
predisposed individuals. Low birth weight children
are also at an increased risk of developing physical,
cognitive and psychological problems all of which
adversely inﬂuence their quality of life [62].
Prenatal infections with Rubella, Inﬂuenza and
Toxoplasmosis have also been hypothesized to have
an aetiological role in the development of adult
schizophrenia via cytokine-induced alteration of
fetal neurodevelopment [63].
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nfections and cardiovascular diseases
n the pathway for the eventual emergence of car-
iovascular diseases such as hypertension, stroke,
schaemic heart disease and cardiomyopathy, the
ole of conventional risk factors such as unhealthy
iet, alcohol ingestion, smoking, obesity and dyslip-
daemia (Table 1) have for long been established.
any studies are now suggesting that infections
re also contributory risk factors in the emer-
ence of all these cardiovascular diseases [64—70].
lthough, the role of infections as risk factors for
ypertension, stroke and ischaemic heart disease
emains inconclusive, there are stronger evidences
n support of infections as primary drivers for some
ardiomyopathies.
Peripartum cardiac failure (PPCF), a cardiomy-
pathy causing cardiac failure during pregnancy
r 6 months after delivery, is a disease of largely
nknown aetiology seen predominantly in black
ultiparous women of poor socio-economic sta-
us [69,71]. In Zaria, northern Nigeria it has been
hown to follow ingestion of high sodium contain-
ng potash which induces heart failure in women
nable to handle excessive salt [72]. Malnutrition,
lcoholism, hypertension and infection-induced
yocarditis are other suggested risk factors for
PCF [69,71]. In Niger, Sub-Saharan Africa, Cenac
t al. suggested a possible aetiological role of
hamydiae pneumoniae in PPCF when they demon-
trated a signiﬁcant higher IgG seropositivity in
atients with PPCF when compared to controls [70].
PCF has also been aetiologically linked to viral
yocarditis [71]. Myocardial biopsies of patients
ith PPCF have revealed features consistent with
iral myocarditis and Coxsackie B virus is thought
o be the most common cause of myocarditis in
ffected patients [71].
In addition to the numerous non-infectious
auses of dilated cardiomyopathy including nutri-
ional deﬁciencies (e.g. thiamine), toxins (e.g.
lcohol), drugs (e.g. adriamycin) and metabolic
isorders (e.g. thyrotoxicosis), infections such as
IV, Chagas’s disease, Lyme disease are also grad-
ally emerging as prominent causes of dilated
ardiomyopathy, especially in the developing world
73]. Idiopathic dilated cardiomyopathy has also
een ascribed to Coxsackie B virus and Toxo-
lasma gondii from serological studies in Africa
64]. Endomyocardial ﬁbrosis (EMF) akin to Loef-
er’s eosinophilic endocarditis in western world is
nother cardiomyopathy prevalent in developing
ountries. Jaiyesimi [74] and Andy et al. [75,76] in
igeria have described EMF as a burnt out phase of
elminth-induced hypereosinophilia. Microﬁliaria,
richinella Spirallis, Ascaris Hookworm, Schistoso-
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Table 2 List of non-communicable diseases (NCDs) and their known or probable infectious risk factors.
Disease Infection
Cardiovascular
Atherosclerosis and ischemic heart disease Chlamydiab, CMVb, Herpes Virusb, Dental infectionsb
Hypertension Chlamydiab
Peripartum cardiac failure Coxsackie B virusb, Toxoplasmosisb, Chlamydiab
Endomyocardial ﬁbrosis Loa loab, Toxoplasmosisb, Trichinellab, Ascarisb,
Hookwormb, Schistosomab
Rheumatic fever/rheumatic heart disease Group A ˇ hemolytic Streptococcus
Dilated cardiomyopathy Virusesa, Toxoplasmosisa, Chaga’sa, HIVa, Lyme diseasea,
etc.
Neurology/pyschiatry
Stroke Chlamydiab
Tropical spastic paraparesis Human T lymphotrophic virus type 1a (HTLV1)
Dementia HIVa
Alzheimer’s disease Herpes virusb, Chlamydiab
Multiple sclerosis EBVb, Corona virus
Creutzfeldt-Jakob, Kuru, Familial insomnia Prionsa
Subacute sclerosing panencephalitis (SSPE) Measles virusa
Gullian Barre Syndrome Campylobacter Jejunia
Schizophrenia Intrauterine inﬂuenzab
Motor neuron disease (MND) Virusesb
Chronic fatigue HTLV1b, EBVb
Tics, Obsessive compulsive disorder Group A Streptococcus Agalactiaeb
Autoimmune/endocrine
Type 1 DM Enterovirusesb—–Coxsackie, Mumps, etc.
Graves Disease Yersinia enterolyticab
Sjogren’s disease Helicobacter pylorib
Rheumatoid arthritis/SLE Epstein Barr Virus, Parvovirus, Mycobacterium species,
Human endogenous retroviruse
Polyarteritis nodosa Hepatitis B Virusa
Mixed cryoglobulinaemia Hepatitis C Virusa
Obesity Adenovirus 36b
Reiter’s arthritis Chlamydiaa, Salmonellaa, Shigellaa, Campylobacter
Jejunia, Yersiniaa
Gastrointestinal diseases
Peptic ulcer, Gastritis Helicobacter pyloria
Chronic hepatitis, Liver cirrhosis Hepatitis B Virusa, Hepatitis C Virusa
Primary biliary cirrhosis Helicobacter pylorib
Crohn’s disease Mycobacterium paratuberculosisb
Whipple’s disease Tropheryma whippleia
Malnutrition Several infectionsa
Renal
Nephrotic syndrome/chronic glomerulonephritis Malariaa, Hepatitis B Virusa, Hepatitis C Virusa,
Salmonellaa, Schistosomiasisa, Syphilisa, Leprosy a,
Tuberculosisa, etc.
Acute glomerulonephritis Post  hemolytic streptococcusa
Respiratory
Asthma Chlamydiac, Mycoplasmab, Aspergillusa,
Dermatophagiodesa, Parasitesb
Chronis obstructive pulmonary Disease Chlamydiab, Mycoplasmab, Haemophilusb,
Streptoccocusb
Sarcoidosis Mycobacterium speciesb
Cancers
Primary liver cell carcinoma Hepatitis B Virusa, Hepatitis C Virusa, Aﬂatoxin B1 from
Aspergillus ﬂavusa
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Table 2 (Continued )
Disease Infection
Burkitt’s lymphoma Malaria and Epstein Barr Virusa
Malt lymphoma, gastric lymphoma Helicobacter pyloria
Bladder cancer Schistosoma haematobiuma
Cervical cancer, anal, laryngeal, penile, vulva
cancers
Human Papilloma Virusa
Adult T cell leukemia Human T lymphotrophic virus 1a
Kaposi’s sarcoma Human herpes virus 8a
Hodgkin’s lymphoma, nasopharyngeal cancer, B
cell lymphoma in HIV
Epstein barr virusa
Bile duct cancer Opisthorchis viverrrinia, Chlonorchis sinensisa
Others
Blindness Trachomaa, Onchocerciasisa, Measlesa, etc.
Eclampsia Infectionb [118]? type
Dental caries Several bacteria infectionsa
Hemolytic uremic syndrome Escherichia Coli 0157a
Anemia, arthritis Parvovirus B19a
Bacillary angiomatosis Bartonella henselaea
Chronic lyme arthritis Borrelia Burgdoferia
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a Known infectious risk factor.
b Probable infectious risk factor.
miasis, Giardia Lamblia and Fascioliasis have been
reported to be possible triggers for eosinophilia.
Eosinophils induce EMF probably through the
release of eosinophil basic proteins which are highly
toxic to the endothelia and muscles of the heart,
blood vessels and other organs [75,76].
Infections, peptic ulcer and tropical
splenomegaly syndrome
Following groundbreaking studies by Marshall and
Warren [77], peptic ulcer disease previously
attributed to stress, diet, smoking and other
environmental factors have now been primarily
aetilogically linked due to Helicobacter pylori
infection. Helicobacter pylori is also a major aeti-
ological factor in gastritis, gastric cancers and
mucosa associated lymphomas. Immune-mediated
mechanisms underlie Helicobacter pylori medi-
ated extra-gastric manifestations including such as
ischemic heart disease and autoimmune diseases
like Sjogren’s syndrome [78].
Malaria, an endemic disease in most developing
countries, has been implicated in the aetiopatho-
genesis of hyperimmune malaria splenomegaly
syndrome, previously called Tropical Splenomegaly
syndrome [79,80]. This syndrome is characterised
by chronic malaria parasitaemia, T-suppressor cell
defect, high IgM antibodies, formation of high
molecular weight immune complexes and hep-
atosplenomegaly [79,80]. It occurs in adults with
t
c
s
a
topionbacterium acne
ood immunity against malaria and responds to pro-
onged antimalarial (proguanil) with regression of
plenomegaly [79].
nfections, malnutrition and obesity
hronic malabsorption in the Tropics is driven pri-
arily by infections of the gastrointestinal mucosa
81]. Protozoan and helminth infections such asGia-
dia intestinalis, Isospora belli, Cryptosporidium
arvum, Strongyloides stercoralis and Capillaria
hilippinensis result in weight loss and growth
tunting by causing chronic diarrhea and by promot-
ng mucosal abnormalities that result in nutrient
alabsorption [81]. Tropical sprue, another cause
f malabsorption of unknown aetiology has been
inked to mucosal damage induced by bacteria tox-
ns of Klebsiella, Enterobacter and Escherichia coli
81]. Uncommon outside the Tropics, Whipple’s dis-
ase (previously an unknown cause of weight loss,
rthritis and diarrhea) is now established to be due
o an infectious agent named Tropheryma whipplei
82].
According to WHO, malnutrition contributes to
0% of under 5 mortality in sub-Saharan with poor
utrition contributing to about 50% of all deaths due
o infections [83]. Malaria, diarrheal disease, tuber-
ulosis, respiratory tract infections, measles and
everal other infectious diseases prevalent in Africa
re known to directly or indirectly induce changes
hat result in malnutrition [83]. Pro-inﬂammatory
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ytokines such as IL-1, IL-6, IL-8 and TNF that may
e released during any of these infections have
een shown to directly induce malnutrition by initi-
ting cellular hypermetabolism, increasing muscle
rotein catabolism, impairing cellular uptake of
atty acids from plasma triglcerides and promoting
izable lost of many minerals and vitamins [84].
Paradoxically, in the concept named
‘Infectobesity’’ infections have been suggested
s risk factors contributing to the development of
besity [85]. Dhurandhar et al. [85] observed that
uman adenovirus type 36 (Ad-36) experimentally
nduced obesity and paradoxically low levels of
erum cholesterol and triglycerides in mice. A role
f adenovirus in human obesity was suggested by a
tudy in India where signiﬁcantly higher prevalence
ate of Ad-36 antibodies was reported in the obese
umans when compared to non-obese (30% vs. 5%)
85]. Adenoviruses are thought to induce obesity
y causing long-term hyperplasia and hyperpro-
iferation of adipocytes [85]. It should be noted
owever that while the viral-associated obesity
n animals has met Koch’s criteria for causation,
n human, infections are risk factors for obesity
equiring concrete causal establishment.
nfections, neuropsychiatric diseases and
hysical disabiliites
he discovery of prions by Prusiner B in the early
980s completely revolutionalised the concept of
n infectious agent [86]. Prions are small pro-
einaceous particles that unlike other infectious
gents lack DNA or RNA [87]. They are the only
nown transmissible agents that may manifest as
nfectious, genetic or sporadic diseases. By caus-
ng neuronal dysfunction leading to vacoulation and
eath of neural cells, proins induce neurodegener-
tive human diseases and they are now established
auses of diseases such as Kuru and Creutzfeldt-
akob disease [87]. Alzheimer’s disease is another
eurodegenerative condition where infections such
s Chlamydia pnuemonia are thought to play an
etiological role [88] but the evidence remains
nconclusive.
In tropical Africa as in most developing countries
f the world many non-communicable neurological
iseases may follow infections. HIV is a known cause
f dementia and has been implicated in several
mmune-mediated neuropsychiatric manifestations
ncluding peripheral neuropathy, transverse myeli-
is and encephalitis [89]. Human T lymphotrophic
irus type 1 (HTLV-I) is an established cause of
ropical spastic paraparesis [90,91]. Self-limiting
europsychiatric manifestations such as peripheral
e
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europathy, psychosis, schizophrenia-like states,
erebellar ataxia, parkinsonism and stroke-like
tates may occasionally be manifestation of severe
alaria and typhoid fever [92—94]. These manifes-
ations are due to direct effects of toxic microbial
roducts on cells of the central nervous system as
ell as due to effect of high levels of cytokine par-
icularly TNF.
Physical disabilities have multiple risk factors
ut it is important to also highlight how some
nfections are worsening the burden of physical
isabilities in the developing world by serving as
rimary drivers of for instance, limb paralysis and
lindness. Poliomyelitis is still endemic in four
ountries of the world and according to the WHO
ne in 200 infections leads to paralysis of the lower
imbs [95]. Nigeria has one the highest incidence of
oliomyelitis cases with high rates of acute ﬂac-
id paralysis resulting in long-term disability of
ffected children [96]. Leprosy is still common in
ndia, Nigeria and South America and it is a major
ause of limb deformity, cosmetic disﬁgurement
nd permanent disabilities [97].
In view of all the forgoing, it is important for
ealth practitioners in the developing world to also
onsider an associated infectious risk factor in the
valuation, management and prevention of neu-
opsychiatric diseases and physical disabilities.
nfections, chronic kidney disease and
ropical nephropathy
ypertension, diabetes mellitus and glomeru-
onephritis are some of the commonest causes of
hronic kidney disease worldwide. While infec-
ions have no established role in hypertensive and
iabetic-related nephropathy, they are often the
ajor aetiological drivers for glomerulonephritis
articularly in developing countries where infec-
ions are highly prevalent [99,100]. Infections can
lso result in kidney diseases by directly or indi-
ectly damaging the renal parenchyma and intersti-
ium [100]. In the entity named Tropical nephropa-
hy, many infections have been shown to cause
enal disease by invasion of the kidney/urinary
ract (e.g. schistosomiasis, tuberculosis, leprosy),
y direct renal injury (e.g. Salmonella) and by
mmune-mediated renal damage (e.g. Plasmod-
um spp., HBV, HCV, Yersinia enterolytica and
hemolytic streptococcus) [99,100]. Perhaps thearliest and the most remarkable example of how
nfections can result in renal disease is the Gilles
nd Hendrichse [101] 1963 account of Nephrosis in
igerian children attributed to Plasmodium malar-
ae. In a large study amongst adults and children in
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Uganda, Kibukamusoke et al. [102] in 1967, estab-
lished a cause and effect relationship between
Plasmodiummalariae and nephrotic syndrome. This
condition now called quartan malarial nephropathy
is due to immune complex mediated damage of the
kidney [21].
Acute glomerulonephritis may follow ˇ
hemolytic streptococcus infections of skin or
throat but it is noteworthy that in some parts
of the Tropics, scabies in children may promote
glomerulonephritis when they become secondarily
infected by ˇ hemolytic streptococcus [103,104].
Aikhonbare and Abdulrahman have given accounts
of acute glomerulonephritis in Nigerian children
following secondary bacterial infection of scabies
skin lesions [103,104]. Since scabies facilitates
infection with  hemolytic skin infection, it also
constitutes a risk factor for glomerulonephritis
demanding preventative interventions.
Infections and asthma
Asthma is a disease with multifactorial risk fac-
tors (Table 1). Infections are also known to be
contributory risk factors in the initiation, symp-
tomatic exacerbation and pathological progression
of the disease [105—108]. House dust mites (e.g.
dermatophagoides farinae) and respiratory tract
infections due to inﬂuenza viruses and Chlamydia
pneumonia are some examples of infections which
can trigger an asthmatic attack and also promote
the progression of the disease [106,108]. Evidence
for the role of house dust mite (dermatophagiodes
pteronnysinus) and aspergillus ﬂavus in trigger-
ing asthma has been suggested by a study from
northern Nigeria where signiﬁcant levels of IgE
antibodies of these agents were found in sera of
patient with asthma [107]. Some other workers
have also reported signiﬁcantly higher antibodies to
Chlamydia pneumonia and Mycoplasma pneumonia
in patients with asthma than normal controls [108].
While these ﬁndings do not prove causality, they
have formed the basis for ongoing research aimed
at elucidating the aetiopathogenetic role of several
infections in asthma.
In Africa, asthma like symptoms follows infec-
tions with several parasitic infections especially
during parasite larval migration through the lungs
of infected individuals [106]. Hookworm, schisto-
somiasis and Strongyloides are typical examples of
parasitic infections where asthma-like symptoms
are known to occur [106]. Routine exclusion of
an associated parasitic infection should therefore
be an integral component of the management of
patients with asthma-like symptoms in the devel-
oping world.
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alaria and red cell genetic defects
emoglobinopathies, glucose-6-phosphate dehy-
rogenase deﬁciency (G6PD) and thalassemia are
xamples of red cell genetic defects whose evo-
utional emergence are thought to have been
romoted by malaria [110—112]. Malaria kills a
hild in Africa every 30 s and according to the WHO
alaria causes 1.5—2 million deaths amongst chil-
ren annually and 90% of these deaths occur in
frica [109]. In other to survive these attacks of
alaria, a protective genetic mutation is thought
o have been induced by an evolutionary pres-
ure of malaria on the red cell genes of affected
opulations conferring recipients with survival and
eproductive advantage over others [109—112].
he evolutionary relationship between malaria and
ickle hemoglobin is supported by striking coinci-
ences in their geographical distribution [112]. By
mpairing malarial growth and development, the
ickle cell trait (heterozygotes, AS) gives survival
dvantage over people with normal hemoglobin
AA) in malaria endemic regions [110]. Unfor-
unately individuals with homozygous state (SS)
enetic red cell defects fail to attain survival advan-
age as they are more likely to have recurrent and
evere attacks of malaria most often leading to
eath. This process by which the heterozygote of
wo alleles of a gene has an advantage over either
f the homozygous states is called balanced poly-
orphism.
Similarly, the genetic mutation leading to G6PD
eﬁcient red cells is thought to have occurred
ecause of the need to survive malaria parasite
nfection [112]. G6PD prevents generation of oxy-
en radicals in red cells and in G6PD deﬁcient
ndividual’s accumulation of oxygen radicals within
ed cells prevents the growth of the malarial par-
site [112]. Despite all these protective genetic
utations, the malaria parasite, like most infec-
ious agents, is continually evolving new strategies
o survive within the human host. For instance, in
rder to avoid the deleterious effects of oxygen rad-
cals on parasite survival in G6PD deﬁciency there
re reports of Plasmodium falciparum specie that
roduce their own G6PD [113].
anobacteria and tissue calciﬁcation
ewly discovered but still controversial bacteria
alled Nanobacteria or infectious calcifying par-
icles have been shown to possess mineralization
roperties in in vitro studies and are suggested to
irectly cause calcium phosphate deposition and
tone formation in tissues that characterize dis-
ases like nephrolithiasis, cholelithiasis, vascular
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Inadequate coverage is usually attributed to insuf-
ﬁcient supply or absence of vaccines, difﬁcult to
reach terrains within communities and rejection of
vaccines due to religious/cultural beliefs and illit-
Table 3 Examples of NCDs prevented and managed
by strategies targeting known microbial aetiological
factors.
NCD Antimicobrial/vaccine
targets
Peptic ulcer disease
gastric cancer
Helicobacter pyloria
Whipple’s disease Tropheryma whippleia
Rheumatic heart
disease
ˇ Hemolytic
streptococcusaompelling needs for novel strategies in the develo
laques, valvular calciﬁcation, prostatic stones and
samomma bodies in ovarian cancer [114,115].
anobacteria were identiﬁed as cell-walled and
elf-propagating infectious particles which differed
rom other known bacteria in their smaller size
equiring electron microscope for identiﬁcation.
f conﬁrmed, Nanobacteria will upturn existing
aradigms of bacteria infections andmay break new
rontiers for understanding and unraveling unknown
ssociations between NCDs and infections.
uman endogenous retroviruses (hervs) and
CDs
tudies of the human genome over the last three
ecades have revealed the existence of endoge-
ous retroviruses which constitute about 1% of the
uman genome [116]. HERVs are closely related
o exogenous animal and human retroviruses and
re referred to as ‘fossil’ viruses because they are
hought to have been acquired by cross-species
ransmission of exogenous retroviruses at some
oint during evolution and are transmitted verti-
ally through the germ-line with inheritance by
uccessive generations in a Mendelian fashion. They
ay provide evolutionary advantage to the infected
ost by protecting against exogenous forms of the
irus but may be harmful when defective viruses
roduced by random mutations recombine with
ther viruses, serve as superantigens or antigenic
imics in promoting disease development [116].
ERVs have been implicated in the aetiopathogen-
sis of autoimmune diseases such as SLE, Sjogren’s
isease and Multiple sclerosis and also in cancers
specially Germ cell cancers [116].
mplications for an infectious role in
mergence of non-communicable
iseases
esign of prevention and control strategies
or NCDs
CDs are diseases with multiplicity of risk factors
Table 1). While focusing and expanding on pre-
enting known risk factors for NCDs there is a need
o identify all novel or emerging risk factors for
he purpose of an integrated and unparallel NCD
ontrol strategy. As evidence gathers for a primary
r precipitating role of infections in many NCDs,
here is a need to re-design NCD control and pre-
entive strategies to also include infection control
hile continuing to recognize NCD aetiopathogen-
sis as spread over a continuum. This review hasworld 25
rought to light the high incidences of various infec-
ions in the developing world and the contributory
ole of infections in programming, initiating, pre-
ipitating and promoting the development of NCDs.
onsequently, an effective NCDs prevention can
nly be achieved in developing countries if infection
ontrols is integrated with control of other envi-
onmental risk factors (Fig. 1). Understanding that
nfections can contribute to NCD causation from
etal life to adulthood, emphasizes the need to
lso include prevention of infection in pregnancy
particularly malaria) and prevention of childhood
nfections (by routine immunization) as integral
lements of NCDs control strategy in the developing
orld.
revention and eradication of NCDs by
ntimicrobial therapy and vaccination
he knowledge of an infectious aetiology of NCDs
as offered the potential for preventing and con-
rolling speciﬁc NCD through interventions that
revent acquisition of the infection (e.g. vaccina-
ion) or eradicates the infection (e.g. antibiotics).
able 3 gives examples of how some NCDs are being
revented by this approach.
Successful vaccination and immunization pro-
rammes have enormous potential of protecting
large population of people from both infectious
iseases and NCDs. Unfortunately, there are still
arriers to achieving optimal and sustainable vac-
ination programmes in many developing countries
ue to multiple factors [117]. Lack of political wills
y local governments, stakeholder apathy and cor-
uption are some examples of factors leading to
ailure of vaccination programmes in many areas.Liver cirrhosis primary
liver cell cancer
Hepatitis B virus
Cervical carcinoma Human papilloma virus
a Vaccines yet to be developed.
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associated infectious risk factors. NB: microbial ﬁngerpr
molecular biology techniques.
eracy. There are also problems of high cost of local
production of vaccines, lack of knowledge of local
antigenic serotypes for many infections and scarcity
of the required expertise and technology needed
for vaccine development in developing countries.
Policy makers in this part of the world must there-
fore be prepared to re-organize and strengthen
their vaccination programmes and also tackle prob-
lems confronting provision of effective vaccination.
Health practitioners must be proactive in initiating
research that identiﬁes prevailing local serotypes of
an infection. Non-governmental organizations and
countries of the developed world have also a role
in providing support and the needed technology for
local vaccine development.
Future directions
As old and novel infectious diseases continue to
emerge and re-emerge, we are faced with the chal-
lenge of not only preventing and managing these
diseases but also determine if they may partic-
ipate in the fusion of risk factors that leads to
emergence of novel or even old NCDs. To suc-
cessfully identify whether any infection is a risk
factor or primary aetiological factor for a NCD,
there is a need for collaborative efforts between
public health physicians, clinicians, pathologist and
molecular biologist. This collaboration should be
aimed at identifying NCD epidemiological trends,
C
T
rontrol in developing countries: identifying and targeting
may include microbial DNA, RNA or protein detected by
linical manifestations and disease pathologies in
elation to exposure to speciﬁc infections. Since
ot all infections are cultivatable, the role of
he molecular biologist is to detect using molecu-
ar biotechnology, microbial ‘‘ﬁnger prints’’ (such
s microbial DNA, RNA or protein) which when
etected may further strengthen the evidence sug-
esting a link between an infection and a NCD. A
urveillance network made of all these stakeholders
s therefore very necessary and most be strength-
ned in developing countries.
It should be emphasized that there is a need
or all developing countries to make conscious
fforts at implementing the WHO stepwise NCD
urveillance approach [4] while recognizing the
eed to also include infectious risk factors in NCDs
here infections have strong causal links. Perhaps,
ne of the greatest challenges in this regard, is
he absence of adequate expertise and technology
eeded for detection of microbial ﬁngerprints by
olecular biotechnology. Governmental and NGO
ithin developing countries most therefore take
he responsibility of funding the research, training
nd technology required for molecular diagnosis.onclusion
he developing world is presently experiencing two
aging epidemics of infectious diseases and NCDS.
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ith the increasing recognition of the role of infec-
ions in promoting the emergence of many NCDs,
here is a need to integrate infection control efforts
ith control of other known environmental risk fac-
ors for NCDs. This novel NCD preventive approach
ffers great potential for mitigating the dual infec-
ious diseases and NCDs epidemics in the developing
orld.
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